The proto-oncogene c-src, which encodes a non-receptor-type tyrosine kinase
c-Src, has been shown to be essential for osteoclastic bone resorption by
the finding that the targeted disruption of the c-src gene induced osteopet
rosis in mice, The csk (C-terminal Src family kinase) gene encodes a cytopl
asmic protein-tyrosine kinase that specifically phosphorylates the negative
regulatory site of c-Src (Tyr-527), thereby inhibiting its kinase activity
. To regulate osteoclast function by modulating the kinase activity of c-Sr
c, we constructed an adenovirus vector that carries this gene. The recombin
ant adenovirus vector carrying csk cDNA induced Csk expression in mouse ost
eoclast-like cells formed in vitro and clearly reduced c-Src kinase activit
y in a dose-dependent manner. The expression of Csk caused cytoskeletal dis
organization of osteoclast-like cells and strongly suppressed pit-forming a
ctivity of the cells in vitro. In addition, the viral vector carrying csk g
ene dramatically suppressed interleukin-1 alpha-induced bone resorption in
vivo. Conversely, kinase-inactive Csk caused an increase in c-Src kinase ac
tivity and bone resorbing activity of the cells both in vitro and in vivo,
acting as a dominant negative molecule against intrinsic Csk, These finding
s indicate that the inhibition of c-Src activity by adenovirus vector-media
ted csk expression offers an efficient means for inhibiting pathological bo
ne resorption by suppressing osteoclast function.